Home » Merck to Buy SmartCells in Deal Worth More Than $500 Million
Merck to Buy SmartCells in Deal Worth More Than $500 Million
Drugmaker Merck & Co. said Thursday it will buy insulin developer SmartCells Inc. in a deal that may exceed $500 million if development and regulatory milestones are met.
StarTribune
StarTribune
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May